NE3107
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for NE3107, covering 2023-02-08 to 2026-02-19. Get the full timeline:
Most recent: Clinical Trial Update: NE3107 in Adults With Neurological Symptoms of Long COVID [Phase 2]